The price-to-earnings ratio for Resmed Inc (NYSE: RMD) is above average at 26.56x. The 36-month beta value for RMD is also noteworthy at 0.78. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 4 rating it as “overweight,” 6 rating it as “hold,” and 1 rating it as “sell.”
The public float for RMD is 145.58M, and at present, short sellers hold a 6.26% of that float. The average trading volume of RMD on May 01, 2025 was 1.14M shares.
RMD) stock’s latest price update
The stock price of Resmed Inc (NYSE: RMD) has plunged by -0.48 when compared to previous closing price of 237.74, but the company has seen a 10.33% gain in its stock price over the last five trading sessions. zacks.com reported 2025-04-25 that Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
RMD’s Market Performance
Resmed Inc (RMD) has experienced a 10.33% rise in stock performance for the past week, with a 5.69% rise in the past month, and a -6.43% drop in the past quarter. The volatility ratio for the week is 3.02%, and the volatility levels for the past 30 days are at 3.82% for RMD. The simple moving average for the past 20 days is 8.21% for RMD’s stock, with a 1.60% simple moving average for the past 200 days.
Analysts’ Opinion of RMD
Many brokerage firms have already submitted their reports for RMD stocks, with Morgan Stanley repeating the rating for RMD by listing it as a “Overweight.” The predicted price for RMD in the upcoming period, according to Morgan Stanley is $280 based on the research report published on March 19, 2025 of the current year 2025.
RMD Trading at 5.88% from the 50-Day Moving Average
After a stumble in the market that brought RMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.06% of loss for the given period.
Volatility was left at 3.82%, however, over the last 30 days, the volatility rate increased by 3.02%, as shares surge +6.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.61% upper at present.
During the last 5 trading sessions, RMD rose by +10.33%, which changed the moving average for the period of 200-days by +15.51% in comparison to the 20-day moving average, which settled at $218.64. In addition, Resmed Inc saw 3.45% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RMD starting from Sandercock Brett, who sale 1,000 shares at the price of $215.58 back on Apr 08 ’25. After this action, Sandercock Brett now owns 89,864 shares of Resmed Inc, valued at $215,580 using the latest closing price.
Farrell Michael J., the Chief Executive Officer of Resmed Inc, sale 8,009 shares at $209.85 during a trade that took place back on Apr 07 ’25, which means that Farrell Michael J. is holding 455,472 shares at $1,680,699 based on the most recent closing price.
Stock Fundamentals for RMD
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.59 for the gross margin
The net margin for Resmed Inc stands at 0.26. The total capital return value is set at 0.24. Equity return is now at value 25.81, with 18.26 for asset returns.
Based on Resmed Inc (RMD), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at 1.97. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is 226.6.
Currently, EBITDA for the company is 1.53 billion with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of 6.89. The receivables turnover for the company is 5.53for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.
Conclusion
In summary, Resmed Inc (RMD) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
